Updated:
PharmaLex
PharmaLex is a asset manager based in Friedrichsdorf, founded 2003; the Altss profile covers its classification, headquarters, registration, AUM band, and key...
PharmaLex
General information
Firm type
Asset Manager
Year founded
2003
Location
Region
Europe
Country
Germany
City
Friedrichsdorf
Corporate office
Friedrichsdorf, Germany
Sector focus
Frequently asked questions
What is the relationship between PharmaLex and Cencora (formerly AmerisourceBergen)?
Cencora acquired PharmaLex in January 2022 for approximately €1.28 billion (per Reuters, 2022). Since the deal, PharmaLex has operated as a portfolio company within Cencora's suite of solutions for pharmaceutical manufacturers, with the parent company integrating its services into a broader value proposition for life-science clients.
What specific services does PharmaLex provide to the life sciences industry?
The firm's primary service lines include regulatory affairs strategy and filing, pharmacovigilance and drug safety, clinical trial support, quality management and compliance, and market access consulting. It also advises on digital health regulation and the integration of acquired R&D assets, serving both small biotechs and top-20 pharmaceutical companies.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: